Aarti Pharmalabs Limited manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xanthine derivatives in India. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai, India.
Aarti Pharmalabs Dividend Announcement
• Aarti Pharmalabs announced a semi annually dividend of ₹1.00 per ordinary share which will be made payable on 2024-09-02. Ex dividend date: 2024-07-31
• Aarti Pharmalabs annual dividend for 2024 was ₹3.00
• Aarti Pharmalabs's trailing twelve-month (TTM) dividend yield is 0.47%
Aarti Pharmalabs Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2024-07-31 | ₹1.00 | semi annually | 2024-09-02 |
| 2024-02-19 | ₹2.00 | semi annually | 2024-03-08 |
Aarti Pharmalabs Dividend per year
Aarti Pharmalabs Dividend Yield
Aarti Pharmalabs current trailing twelve-month (TTM) dividend yield is 0.47%. Interested in purchasing Aarti Pharmalabs stock? Use our calculator to estimate your expected dividend yield:
Aarti Pharmalabs Financial Ratios
P/E ratio25.16
PEG ratio0.51
P/B ratio3.09
ROE12.98%
Payout ratio0.00%
Current ratio2.01
Quick ratio0.96
Cash Ratio0.06
Aarti Pharmalabs Dividend FAQ
Does Aarti Pharmalabs stock pay dividends?
Aarti Pharmalabs does not currently pay dividends to its shareholders.
Has Aarti Pharmalabs ever paid a dividend?
No, Aarti Pharmalabs has no a history of paying dividends to its shareholders. Aarti Pharmalabs is not known for its dividend payments.
Why doesn't Aarti Pharmalabs pay dividends?
There are several potential reasons why Aarti Pharmalabs would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Aarti Pharmalabs ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Aarti Pharmalabs has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Aarti Pharmalabs a dividend aristocrat?
Aarti Pharmalabs is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Aarti Pharmalabs a dividend king?
Aarti Pharmalabs is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Aarti Pharmalabs a dividend stock?
No, Aarti Pharmalabs is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Aarti Pharmalabs stocks?
To buy Aarti Pharmalabs you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Aarti Pharmalabs stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Aarti Pharmalabs stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.